Week 2 Study Guide: Epidemiology and Communicable Disease Nursing Control of Communicable Diseases

Introduction to Community Health Nursing and Epidemiology

  • Presenter: Dr. Becky Nauta

  • Course: NR 442 Community Health Nursing

  • Timeline: Week 2 content covering Chapter 5 (Epidemiology) and Chapter 26 (Communicable Disease).

Chapter 5: Fundamentals of Epidemiology

  • Definition: Epidemiology is the study of the distribution and determinants of health and disease in human populations. According to the World Health Organization (WHO, 2017), it serves as the principal science of public health.

  • Objectives of Study:

    • Identify epidemiological models to explain disease and health patterns.

    • Use epidemiological methods to describe community/aggregate health status.

    • Calculate rates to characterize population health.

    • Apply methods across levels of prevention: primary, secondary, and tertiary.

    • Evaluate various study designs for researching health problems.

Epidemiological Models for Disease Control and Prevention

  • Person-Place-Time Model: Investigations compare people who became ill with those who remained healthy.

    • Person (Who): Demographic characteristics, health status, and disease status.

    • Place (Where): Geographic location, climate, environmental conditions, and the political/social environment.

    • Time (When): Time of day, week, month, and secular trends spanning months or years.

  • Types of Epidemiology:

    • Descriptive Epidemiology: Focuses on the amount and distribution of disease. It is primarily used by public health professionals to identify patterns that frequently indicate possible causes.

    • Analytic Epidemiology: Examines complex relationships among various determinants of disease. It investigates the "why" behind disease, focusing on etiology (causes).

  • Epidemiological Triangle: This model examines the interaction of three elements:

    • Agent (Etiologic Factors):

      • Nutritive elements: Excessive amounts or deficiencies.

      • Chemical agents: Poisons and allergens.

      • Physical agents: Ionizing radiation and mechanical factors.

      • Infectious agents: Metazoa, protozoa, bacteria, fungi, rickettsia, and viruses.

    • Host (Susceptibility or Response): Influenced by genetic makeup, age, sex, ethnic group, physiological state, prior immunological experience (active/passive), intercurrent or preexisting disease, and human behavior.

    • Environment (Extrinsic Factors): Factors that influence the existence of the agent or susceptibility of the host.

      • Physical environment.

      • Biological environment: Human population, flora, and fauna.

      • Socioeconomic environment: Occupation, urbanization, economic development, and social disruption.

  • Wheel Model of Human-Environment Interaction: Consists of a central hub representing the host and its characteristics, surrounded by environmental layers (biological, social, and physical).

  • Web of Causation Model: Illustrates the complexity of relationships among causal variables, specifically used for chronic conditions like heart disease.

  • Ecosocial Approach: Emphasizes macro-level socioenvironmental factors along with microbiological processes. It challenges individually focused risk factor approaches by looking at the evolution of health and illness through a broader lens (Smith and Lincoln, 2011).

Mathematical Calculation of Epidemiological Rates

  • Definition of Rates: Arithmetic expressions that provide a count of an event relative to the size of the population. A rate is a proportion multiplied by a constant (kk), such as per 10001000, 10,00010,000, or 100,000100,000 people.

  • General Formula:     Rate=Number of health events in a specified periodPopulation in the same area in the same specified period×k\text{Rate} = \frac{\text{Number of health events in a specified period}}{\text{Population in the same area in the same specified period}} \times k

  • Morbidity Rates:

    • Incidence Rate: The number of new cases or conditions in a population at risk during a specific time.         Incidence Rate=Number of new cases in given time periodPopulation at risk in same time period×1000\text{Incidence Rate} = \frac{\text{Number of new cases in given time period}}{\text{Population at risk in same time period}} \times 1000

    • Attack Rate: A specialized incidence rate describing the number of new cases specifically among those exposed to a disease.

    • Prevalence Rate: Represents all cases (new and existing) of a specific disease or condition at a given time.         Prevalence Rate=Number of existing casesTotal population×1000\text{Prevalence Rate} = \frac{\text{Number of existing cases}}{\text{Total population}} \times 1000

  • Calculation Examples (Reference Page 14):

    • Prevalence calculation: 2504000=0.0625\frac{250}{4000} = 0.0625. Multiplication by 10001000 result: 62.562.5 per 10001000.

    • Incidence calculation: 754000−250=753750=0.02\frac{75}{4000 - 250} = \frac{75}{3750} = 0.02. Multiplication by 10001000 result: 2020 per 10001000.

  • Other Statistical Rates:

    • Age-Specific Rate: Characterizes a particular age group.         Age-Specific Rate=Number of cases in a specific age category at a specified timePopulation in that same age category at that same time×k\text{Age-Specific Rate} = \frac{\text{Number of cases in a specific age category at a specified time}}{\text{Population in that same age category at that same time}} \times k

    • Proportionate Mortality Ratio (PMR): The percentage of deaths resulting from a specific cause relative to deaths from all causes.

    • Crude Rates: General rates for the whole population.

    • Age-adjusted Rates: Standardized rates that allow for comparisons by removing the effect of age distribution differences.

    • Infant Mortality Rate: Specific to deaths in infants.

Concepts of Risk and Causality

  • Risk Definitions:

    • Risk: The probability of an adverse event occurring.

    • Risk Factor: A specific exposure factor, often external, that increases the likelihood of disease.

    • Attributable Risk: An estimate of the disease burden in a population.

    • Relative Risk Ratio: Calculated by dividing the incidence rate of disease in the exposed population by the incidence rate in the non-exposed population.

  • Establishing Causality: The primary goal is identifying etiological factors to develop prevention and treatment. Six criteria establish a cause-and-effect relationship:

    1. Strength of association: A strong correlation between cause and effect.

    2. Dose-response relationship: Increased exposure leads to increased risk/effect.

    3. Temporally correct relationship: The cause must precede the effect.

    4. Biological plausibility: The relationship makes sense biologically.

    5. Consistency with other studies: Findings are replicated across research.

    6. Specificity: A specific cause leads to a specific effect.

Prevention, Screening, and Surveillance

  • Levels of Prevention:

    • Primary Prevention: Health promotion and specific protection to prevent the occurrence of disease.

    • Secondary Prevention: Screenings and examinations for early diagnosis and treatment.

    • Tertiary Prevention: Limitation of disability and rehabilitation for those with irreversible disease.

  • Screening:

    • Identifies risk factors and disease in the earliest stages.

    • Classified as Secondary Prevention because indications appear after pathological changes occur.

    • Requires adequate follow-up treatment planning.

    • Pre-requisite: Medically sound treatment and follow-up must exist.

  • Surveillance: A mechanism for the ongoing collection of community health information, essential for responsive public health programs.

  • Health Services Epidemiology: Focuses on patterns of health care delivery, evaluation of community service use, affordability, and identifying barriers that contribute to excess morbidity in at-risk groups.

Epidemiological Research Methods

  • Analytic Epidemiology - Observational Studies:

    • Cross-sectional Studies: Prevalence or correlational studies. They examine relationships between causal factors and disease at one specific point in time. Note: It is impossible to make definitive causal inferences from these.

    • Retrospective Studies: Compare individuals with a condition (cases) to those without (controls). Data collection looks backward in time.

    • Prospective Studies: Monitor a disease-free group (cohort) over time to determine if and when disease occurs. The cohort shares a common experience.

  • Analytic Epidemiology - Experimental Design:

    • Randomized Clinical Trial (RCT): Subjects are assigned to experimental or control groups to test treatments or prevention strategies. Requires strict ethical review regarding human subject rights.

Chapter 26: Communicable Disease

  • Current Challenges: emergence of new pathogens, reemergence of old pathogens, and the appearance of drug-resistant pathogens.

  • Vectorborne Infections on the Rise:

    • Lyme disease.

    • Rocky Mountain spotted fever.

    • St. Louis encephalitis.

    • West Nile Encephalitis.

    • Zika.

  • Healthy People 2030 Focus Areas:

    1. Immunization and infectious diseases.

    2. Sexually transmitted diseases (STDs).

    3. HIV.

Principles of Communicable Infection

  • Multicausation: Disease etiology is a complex result of the interaction between the Host (human), Infectious Agent, and Environment.

  • Spectrum of Infection:

    • Subclinical Infection: No overt symptoms.

    • Infections: Invasion of the host.

    • Infectious Disease: Clinically apparent illness.

    • Communicable Disease: Can be transmitted from one person to another.

    • Case: A person diagnosed with the disease.

    • Carriers: Persons who harbor the agent without showing signs of disease but can infect others.

  • Stages of Infection:

    1. Latent Period: Agent has invaded and replicated but is not yet shed.

    2. Communicable Period: Begins with the shedding of the agent.

    3. Incubation Period: Time from initial invasion to the first appearance of symptoms. This may overlap with the communicable period.

  • Spectrum of Disease Occurrence:

    • Endemic: Consistent, expected level of disease in a geographic area.

    • Outbreak: Unexpected occurrence in a limited area for a limited time.

    • Epidemic: Unexpected increase over an extended period in a geographic area.

    • Pandemic: Steady occurrence worldwide or over a large geographic area.

Chain of Transmission and Control

  • Six Links: Infectious agents, Reservoirs, Portals of exit, Modes of transmission, Portals of entry, and Host susceptibility.

  • Modes of Transmission:

    • Direct: Person-to-person.

    • Indirect:

      • Vectors: Animals (e.g., insects) that transmit agents biologically or mechanically.

      • Fomites: Inanimate objects (e.g., doorknobs, needles) that transport microbes.

  • Host Susceptibility Factors: Age, health status, and behaviors.

  • Breaking the Chain:

    • Controlling the agent: Eradication or reduction.

    • Eradicating nonhuman reservoirs.

    • Controlling human reservoirs:

      • Quarantine: Isolation during the incubation period.

    • Controlling Portals: Isolation of sick persons and implementation of Universal Precautions.

Immunity and Vaccine Management

  • Levels of Control:

    • Control: Reducing incidence (new cases) or prevalence (existing cases).

    • Elimination: Reducing prevalence/incidence to near zero in a specific geographic area.

    • Eradication: Reducing worldwide incidence to zero (e.g., smallpox in 1977).

  • Types of Immunity:

    • Natural Immunity: Species-specific resistance.

    • Acquired Immunity: Gained through exposure or vaccination.

    • Active Immunity: Host produces own antibodies (via infection or vaccine).

    • Passive Immunity: Transfer of antibodies (e.g., mother to infant, or immune globulin).

    • Herd Immunity: Resistance of a group to invasion based on a high proportion of immune members.

  • Vaccine Failures:

    • Primary Vaccine Failure: Failure of the vaccine to stimulate an immune response.

    • Secondary Vaccine Failure: Waning of immunity after an initially successful response.

  • Vaccine Logistics:

    • Cold Chain: Ensuring vaccines are kept at designated temperatures. Deviations result in loss of potency.

    • Transport: Uses ice packs and liquid crystal/shipping indicators that change color during temperature fluctuations.

    • Vaccine Information Statements (VIS): Must be used for patient education.

  • Contraindications and Safety:

    • Postpone vaccination if the patient has a moderate or severe febrile illness.

    • Pregnancy: Use only inactivated vaccines; avoid live vaccines.

    • Immunocompromised: Avoid live vaccines.

    • Documentation: Must include vaccine name, date, type, manufacturer, lot number, VIS date, and the credentials/address of the administrator.

    • VAERS: Vaccine Adverse Event Reporting System; managed by the CDC.

Levels of Communicable Disease Prevention

  • Primary Prevention: Prevent transmission and pathology in exposed individuals.

  • Secondary Prevention: Detect and treat infected persons early (e.g., screening and contact tracing).

  • Tertiary Prevention: Care for persons with disease to ensure cure or maintain quality of life.